Abstract:Dietary fibre intake is negatively associated with stroke and overall mortality. A plausible hypothesis is that this happens via the gut microbiota, producing metabolites known as short-chain fatty acids (SCFAs) during fibre fermentation. Indeed, our unpublished data showed that low-fibre (LF) intake worsens stroke outcomes while high-fibre (HF) intake ameliorates it. Thus, we aimed to investigate whether switching from a LF diet pre-stroke to either a HF diet or supplementation with SCFAs post-stroke can improve functional and histological outcomes. We also aimed to determine if this effect is dependent on SCFAs-sensing G-protein coupled receptors GPR41, GPR43, and GPR109A. Male C57BL/6J mice (8–9 weeks, n = 8/group) were randomized and treated with a LF diet for 4-weeks prior to photothrombotic stroke surgery. Post-stroke, the mice were either fed with LF, HF or SCFAs for 7-days. Using MRI, we observed no difference in the infarct volume at day 1 (D1) post-stroke. However, a HF diet and SCFAs supplementation reduced infarct volume at day 7 (D7) (mean brain infarct volume ± SEM; LF:13.52 ± 2.43 mm3 vs HF:7.71 ± 1.12 mm3 vs SCFAs:5.25 ± 1.18 mm3, P = 0.007), and improved brain recovery rate (LF:64.93 ± 2.94% vs HF:78.06 ± 1.98% vs SCFAs:85.05 ± 2.45%, P < 0.001). High-fibre and SCFAs supplementation improved wire-hanging grip strength and coordination at D7, which measures motor function (mean % improvement ± SEM; LF:12.59 ± 2.66% vs HF:69.77 ± 8.44% vs SCFAs:97.42 ± 1.54%, P < 0.001). Immunofluorescence was performed to access gut barrier integrity, immune cell infiltration and neurogenesis in the brain at D7. HF and SCFAs improved gut barrier integrity (ZO-1, P < 0.001). Moreover, SCFAs-treated mice had fewer neutrophils (MPO+, P = 0.017) and more neuroblasts (DCX+/Tuj1+, P < 0.001) in the infarct core, with a positive correlation between DCX+/Tuj1+ and recovery rate post-stroke (R2 = 0.50, P < 0.001). To identify the receptors by which SCFAs improve stroke recovery, wild-type (WT) and GPR41/43/109a-/- mice (8–9 weeks, n = 8/group) were fed a HF diet pre- and post-stroke. GPR41/43/109a-/- mice showed worse stroke outcomes with larger brain infarct volume at D1 (P = 0.048) and D7 (P = 0.008), and worse recovery rate (P = 0.002). Consistent with this, wire-hanging grip strength was reduced (P < 0.001) at D7. In addition, compared to WT mice, GPR41/43/109a-/- mice had a leaky gut (P < 0.001), more neutrophils (P = 0.007) and very few neuroblasts (P = 0.011) in the infarct core. A high-fibre diet, resulting in the production of SCFAs, targets GPR41/43/109a signalling to reduce stroke-induced brain injury and improve functional recovery post-stroke. This improvement is likely to occur via neurogenesis and the suppression of the inflammatory response in the ischaemic brain.

The neuroprotective effect of short-chain fatty acids against hypoxia-reperfusion injury

Fecal microbiota transplantation and short‐chain fatty acids protected against cognitive dysfunction in a rat model of chronic cerebral hypoperfusion

Cell-Free Supernatant of Lactobacillus rhamnosus and Bifidobacterium breve Ameliorates Ischemic Stroke-Generated Neurological Deficits in Rats

The microbiota-gut-brain axis participates in chronic cerebral hypoperfusion by disrupting the metabolism of short-chain fatty acids

The Neuroprotective Effect of Short Chain Fatty Acids Against Sepsis-Associated Encephalopathy in Mice

Short-Chain Fatty Acids Reduce Oligodendrocyte Precursor Cells Loss by Inhibiting the Activation of Astrocytes via the SGK1/IL-6 Signalling Pathway

Mechanisms of Blood–Brain Barrier Protection by Microbiota-Derived Short-Chain Fatty Acids

Short-chain fatty acid on blood-brain barrier and glial function in ischemic stroke

Protective role of short chain fatty acids against Angiotensin II-induced mitochondrial dysfunction in brain endothelial cells: Potential role of Heme Oxygenase 2

Omega-3 Fatty Acids Protect the Brain Against Ischemic Injury by Activating Nrf2 and Upregulating Heme Oxygenase 1

Protective Role of Short-Chain Fatty Acids against Ang- II-Induced Mitochondrial Dysfunction in Brain Endothelial Cells: A Potential Role of Heme Oxygenase 2

A novel neuroprotective strategy for ischemic stroke: transient mild acidosis treatment by CO2 inhalation at reperfusion.

Oral Supplementation With Butyrate Improves Myocardial Ischemia/Reperfusion Injury Via A Gut-Brain Neural Circuit

Protective effects of fecal microbiota transplantation against ischemic stroke and other neurological disorders: an update

Abstract W P250: Food Restriction Ameliorates Neuroinflammation and Provides Protection in a Mouse Model of Ischemic Stroke

Fecal microbiota transplantation and replenishment of short-chain fatty acids protect against chronic cerebral hypoperfusion-induced colonic dysfunction by regulating gut microbiota, differentiation of Th17 cells, and mitochondrial energy metabolism

Brief exposure of neuronal cells to levels of short chain fatty acids observed in human systemic circulation impair the cell lipid metabolism resulting in associated cell death by apoptosis

Neuroprotective Effects of an Edible Pigment Brilliant Blue FCF against Behavioral Abnormity in MCAO Rats

S-44-4: POST-STROKE SUPPLEMENTATION WITH SHORT-CHAIN FATTY ACIDS ACCELERATES RECOVERY IN MICE VIA THE G-PROTEIN COUPLED RECEPTORS

Enriched Endogenous Omega-3 Polyunsaturated Fatty Acids Protect Cortical Neurons from Experimental Ischemic Injury

Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia